| Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ... Progress in neurobiology 132, 96-168, 2015 | 528 | 2015 |
| Selective autophagy as a potential therapeutic target for neurodegenerative disorders A Scrivo, M Bourdenx, O Pampliega, AM Cuervo The Lancet Neurology 17 (9), 802-815, 2018 | 346 | 2018 |
| The different autophagy degradation pathways and neurodegeneration A Fleming, M Bourdenx, M Fujimaki, C Karabiyik, GJ Krause, A Lopez, ... Neuron 110 (6), 935-966, 2022 | 293 | 2022 |
| Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome M Bourdenx, A Martín-Segura, A Scrivo, JA Rodriguez-Navarro, ... Cell 184 (10), 2696-2714. e25, 2021 | 249 | 2021 |
| Proteome-wide analysis of chaperone-mediated autophagy targeting motifs P Kirchner, M Bourdenx, J Madrigal-Matute, S Tiano, A Diaz, BA Bartholdy, ... PLoS biology 17 (5), e3000301, 2019 | 206 | 2019 |
| Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases M Bourdenx, J Daniel, E Genin, FN Soria, M Blanchard-Desce, E Bezard, ... Autophagy 12 (3), 472-483, 2016 | 204 | 2016 |
| Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates ML Arotcarena, S Dovero, A Prigent, M Bourdenx, S Camus, G Porras, ... Brain 143 (5), 1462-1475, 2020 | 201 | 2020 |
| Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies M Bourdenx, NS Koulakiotis, D Sanoudou, E Bezard, B Dehay, ... Progress in neurobiology 155, 171-193, 2017 | 195 | 2017 |
| Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice B Caballero, M Bourdenx, E Luengo, A Diaz, PD Sohn, X Chen, C Wang, ... Nature Communications 12 (1), 1-18, 2021 | 167 | 2021 |
| Exosomes, an unmasked culprit in neurodegenerative diseases FN Soria, O Pampliega, M Bourdenx, WG Meissner, E Bezard, B Dehay Frontiers in neuroscience 11, 245886, 2017 | 149 | 2017 |
| Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression M Bourdenx, S Dovero, M Engeln, S Bido, MF Bastide, N Dutheil, ... Acta neuropathologica communications 3, 1-15, 2015 | 134 | 2015 |
| In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains F Cavaliere, L Cerf, B Dehay, P Ramos-Gonzalez, F De Giorgi, ... Neurobiology of disease 103, 101-112, 2017 | 124 | 2017 |
| Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death M Bourdenx, E Bezard, B Dehay Frontiers in neuroanatomy 8, 83, 2014 | 108 | 2014 |
| Systemic gene delivery to the central nervous system using Adeno-associated virus M Bourdenx, N Dutheil, E Bezard, B Dehay Frontiers in molecular neuroscience 7, 50, 2014 | 105 | 2014 |
| Selective inactivation of striatal FosB/ΔFosB-expressing neurons alleviates L-DOPA–induced dyskinesia M Engeln, MF Bastide, E Toulmé, B Dehay, M Bourdenx, E Doudnikoff, ... Biological psychiatry 79 (5), 354-361, 2016 | 92 | 2016 |
| Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies ML Arotcarena, M Bourdenx, N Dutheil, ML Thiolat, E Doudnikoff, ... JCI insight 4 (16), 2019 | 66 | 2019 |
| Protective role of chaperone-mediated autophagy against atherosclerosis J Madrigal-Matute, J de Bruijn, K van Kuijk, DF Riascos-Bernal, A Diaz, ... Proceedings of the National Academy of Sciences 119 (14), e2121133119, 2022 | 61 | 2022 |
| Reciprocal regulation of chaperone-mediated autophagy and the circadian clock YR Juste, S Kaushik, M Bourdenx, R Aflakpui, S Bandyopadhyay, ... Nature Cell Biology 23 (12), 1255-1270, 2021 | 55 | 2021 |
| Targeting α‐synuclein: Therapeutic options B Dehay, M Decressac, M Bourdenx, I Guadagnino, PO Fernagut, ... Movement Disorders 31 (6), 882-888, 2016 | 50 | 2016 |
| Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates M Bourdenx, A Nioche, S Dovero, ML Arotcarena, S Camus, G Porras, ... Science advances 6 (20), eaaz9165, 2020 | 49 | 2020 |
Erwan BezardUniversity of BordeauxVerified email at u-bordeaux.fr
